Table 2.
(After Roerden [27]). Precautionary and emergency measures
Side effects | Precautionary and emergency measures |
---|---|
systemic toxicity of local anesthetics (LAST) | Termination of the TLA application |
Oxygenation, treatment of seizures (benzodiazepine), resuscitation (if necessary), administration of 20% lipid emulsion | |
Continuous monitoring of vital parameters | |
Neurological symptoms (seizures, unconsciousness, restlessness) | Termination of the TLA application |
Oxygen supply, airway management, treatment of seizures (benzodiazepines), ECG monitoring if necessary | |
Apnea following cerebral toxicity | Termination of the TLA application |
Oxygen supply, resuscitation, continuous monitoring of vital parameters | |
Cardiovascular symptoms (bradycardia, hypotension, cardiac arrhythmias) | Termination of the TLA application |
Oxygenation, ECG monitoring | |
Treatment according to the ECG findings | |
Methemoglobinemia | Termination of the TLA application |
Oxygenation | |
Application of Methylene Blue | |
treatment of seizures (benzodiazepines) | |
Pneumothorax | Use of non-ground needles in deep areas/ axilla |
Application of TLA in the axilla under sonographic control | |
Continuous monitoring of vital parameters | |
Chest x-ray | |
Chest tube/ needle decompression if necessary |